Table 1 Borderline Ovarian Tumors Examined by Karyotyping, High Resolution-CGH, and Microsatellite Instability Analysis.

1/01-642

mucinous

no

no

47, XX, +12[4]/47, XX, +7[3]/45, XX, -6[3]/46, XX[63]

rev ish enh(1q22q32, 2p25, 2q22q24, 2q32q33, 3p12p14, 3p22, 3p23, 3p24, 3q12q13, 3q24, 3q25, 5p14, 5q14q22, 6q12q21, 6q22q23, 8q13, 8q21, 8q22q24, 9p13p21, 9p23, 10q21, 18q12), dim(1p21, 1p31pter, 7q11, 11p15, 11q12q14, 11q23, 12q23, 12q24, 13q12, 13q14, 13q33q34, 14q21q24, 14q31q32, 15q13q14, 15q22q24, 17p11p13, 17q, 19p13, 19q, 22q11q13)

MSS

2/01-700

mucinous

no

no

46, XX[116]

rev ish enh(8q23, 9p23), dim(1p34p35, 7q11, 17p12p13, 19p13, 19q13, 22q11q12)

MSS

3/01-839

serous

yes

non-invasive implants

46, XX, t(3;17) (q13;q24)[2]/46, XX[45]

rev ish enh(3p13, 9p23p24), dim(1p33pter, 7q11, 9q34, 11q13, 12q24, 16p11p13, 17p12pter, 17q12q21, 19p13, 19q, 22q11q13)

no DNA available

4/01-844

mucinous

no

no

46, XX, +12, -22[7]/46, XX[19]

no DNA available

MSS

5/02-1

serous

yes

no

46, XX[16]/92, XXXX[23]

rev ish enh(2q22q24, 2q31q32, 3p12, 3q12q13, 4p15, 4q13, 5p14, 5q14q23, 6q15q16, 8q22, 8q23, 13q21q31, 13q32, 21q21), dim(1p32pter, 2q37, 3p21, 4q35, 5q35, 6p21, 6p22, 6q25, 7q11, 9q22, 9q33qter, 10q26, 11q12q13, 12p11p12, 12p13, 12q23q24, 14q31, 15q22q24, 16p11p13, 16q22q23, 17p11p13, 17q11q21, 17q22q24, 19p13, 19q13, 20q11q13, 21q22, 22q11q13)

MSS

6/02-329

serous

yes

invasive implants

46, XX[28]

no imbalances

no DNA available

7/02-828 A

Serous (right ovary)

yes

no

46, XX[13]/92, XXXX[7]

rev ish enh(4p15, 8q22q23, 13q22q31, 13q32), dim(1p32p36, 7p12p13, 7q11, 9q34, 11q12q13, 12p11p12, 12q23, 12q24, 15q22q24, 16p13, 17p12pter, 17q11q21, 19, 22q11q13)

MSS

8/02-829 B

serous (left ovary)

yes

no

46, XX[106]/92, XXXX[9]

no DNA available

--

9/03-325 A

serous (right ovary)

yes

no

46, XX[15]

rev ish enh(3p12p14, 3q13, 5p14, 6q15q16, 8q22q23, 9p21, 18q12), dim(1p31pter, 2q37, 7q11, 11q12q13, 12q24, 16p11p13, 17p11p13, 17q11q21, 17q23q25, 19p, 19q13, 22q11q13)

MSS

10/03-328 B

serous (left ovary)

yes

no

46, XX[15]

no imbalances

MSS

11/03-401

serous

no

no

Culture failure

rev ish enh(1p32pter, 1q21q22, 2p11p12, 2q37, 3p21, 4p16, 6p12p21, 9q33qter, 10q22q23, 10q24, 10q25, 10q26, 11q11q14, 12q24, 14q32, 15q22q25, 16p, 16q13qter, 17p, 17q11q22, 17q24qter, 19p13, 19q13, 20p11p12, 20q13, 22q11q13), dim(6q15q21, 6q22q24)

MSS

12/03-481

serous

yes

no

46, XX[32]

no imbalances

MSS

13/03-620 A

serous (right ovary)

yes

metastasis lympho node

46, XX, der(4) t(3;4) (q13;q34)[15]/46, XX[2]

no imbalances

MSS

14/03-621 B

serous (left ovary)

yes

metastasis lympho node

46, XX, der(4) t(3;4) (q13;q34)[10]/46, XX[5]

no imbalances

MSS

15/03-701

serous

no

no

46, XX[11]

no imbalances

MSS

16/04-36

serous

yes

invasive implants

49, XX, +3, +7, i(8)(q10), +12 [15]/50, idem, +r[2]/50, idem, -r, +mar[2]

rev ish enh(3, 7, 8q13qter, 12), dim(8p22pter)

MSS

17/04-682

mucinous

no

no

46, XX[3]

no DNA available

--

18/04-721

mucinous and serous

no

no

46, XX[18]

no imbalances

MSS

19/04-831 A

serous (left ovary)

yes

invasive implants

46, XX[84]

rev ish enh(2q24, 3p12, 3p13, 8q22q23, 13q22q31), dim(2q36q37, 7q35q36, 9q33q34, 10q25q26, 11q13, 12q23q24, 14q31q32, 15q22q24, 16p11p13, 17p11p13, 17q11q21, 17q22q25, 19p13, 19q13, 20q11q13, 22q)

MSS

20/04-832 B

serous (right ovary)

yes

invasive implants

47, XX, +7[18]

rev ish enh(Xq21q23, 2q22q32, 3p12p13, 3q12q13, 4q12q28, 5p13p14, 5q14q23, 6q12q21, 6q22, 7p12p21, 7q21q34, 8q13q21, 8q22q23, 9p21p24, 11q14q21, 13q21q31), dim(1p32pter, 2q37, 4p16, 6p23, 6q25q26, 9q34, 10q25q26, 11q12q13, 12q23q24, 14q31q32, 15q22q24, 16p11p13, 16q21q24, 17p, 17q11q21, 17q23q24, 19, 20q11q13, 21q22, 22q)

MSS

21/04-1211

mucinous

no

no

Culture failure

no imbalances

MSS

22/04-1213 A

serous (right ovary)

yes

invasive implants

46, XX[3]

rev ish enh(8p11p23, 8q11q24), dim(1p34p35, 15q11q13, 16p11p12)

MSS

23/04-1214 B

serous (left ovary)

yes

invasive implants

46, XX[3]

no DNA available

--